Wolfgang Barth
Nessuna posizione attualmente
Provenienza dei contatti di primo grado di Wolfgang Barth
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
Avontec GmbH
 Avontec GmbH Pharmaceuticals: MajorHealth Technology Avontec is a Phase 2 biopharmaceutical company focused on the development and commercialization of novel therapeutic treatments for inflammatory disease. Its clinical development programs include product candidates for multiple potential inflammatory indications. The two most advanced, AVT-01 in asthma and AVT-02 in psoriasis, have successfully advanced into Phase 2a clinical trials that the firm expects to be completed until the first half of 2008. In addition, there are several candidates in the pipeline based on Avontec's core decoy technology. Avontec operates based on a lean business model with a seasoned management team experienced in clinical development.
2
| Extinct | Pharmaceuticals: Major | 2 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Wolfgang Barth tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
| Eberhard Karls Universität Tübingen | College/University | Doctorate Degree | |
| Johann Wolfgang Goethe-Universität Frankfurt am Main | College/University | Masters Business Admin | |
| Portus Corporate Finance | Corporate Officer/Principal |
Statistiche
Distribuzione geografica
| Germania | 6 |
Settori
| Consumer Services | 3 |
| Health Technology | 3 |
Posizioni
| Chief Tech/Sci/R&D Officer | 2 |
| Director of Finance/CFO | 2 |
| Doctorate Degree | 1 |
| Masters Business Admin | 1 |
| Corporate Officer/Principal | 1 |
Contatti più connessi
| Insiders | |
|---|---|
| Thomas Fink | 4 |
| Stefan W. Henning | 3 |
- Borsa valori
- Insiders
- Wolfgang Barth
- Connessioni Società
